Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($1.28), $0.19 worse than the analyst estimate of ($1.09). Revenue for the quarter came in at $1.66 million versus the consensus estimate of $4.11 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.